Department of Internal Medicine-Transplantation, Erasmus Medical Center-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Clin Transplant. 2009 Sep-Oct;23(5):740-7. doi: 10.1111/j.1399-0012.2009.01014.x. Epub 2009 Jun 26.
It has been reported that donor-reactive T-cell responses may decrease during the first year after HLA-mismatched organ transplantation. We wondered whether donor-reactive T-cell responses directed to minor histocompatibility antigens (mHAgs) or other non-HLA antigens also decrease after HLA-identical living-related (LR) kidney transplantation.
We studied donor-reactive T-cell responses by IFN-gamma and granzyme B (GrB) Elispot assays in 15 HLA-identical LR kidney transplant recipients before, six months and one yr after transplantation. Third-party reactivity was used as control. Patient and donor peripheral blood mononuclear cells were typed for 11 known mHAgs.
During the study period, 60% and 36% of the patients demonstrated donor-reactive IFN-gamma and GrB producing cells (pc), respectively. The number of donor-reactive IFN-gamma and GrB pc was significantly lower than the number of third-party reactive IFN-gamma and GrB pc. After transplantation, donor-reactivity and third-party reactivity were comparable to pre-transplant values. No relation was found in mHAg mismatches between donor and recipient and donor-reactive T-cell response.
Donor-reactivity could be detected before and after HLA-identical LR kidney transplantation, but was not related with the number of mHAg mismatches, and did not decrease after transplantation.
据报道,在 HLA mismatched 器官移植后的第一年,供体反应性 T 细胞应答可能会减少。我们想知道 HLA 相同的活体相关(LR)肾移植后,针对次要组织相容性抗原(mHAgs)或其他非 HLA 抗原的供体反应性 T 细胞应答是否也会减少。
我们通过 IFN-γ 和 granzyme B(GrB)酶联免疫斑点试验在 15 名 HLA 相同的 LR 肾移植受者中进行了供体反应性 T 细胞应答的研究,这些受者在移植前、移植后 6 个月和 1 年进行了研究。将第三方反应性作为对照。患者和供体外周血单核细胞被分为 11 种已知的 mHAgs。
在研究期间,60%和 36%的患者分别表现出供体反应性 IFN-γ和 GrB 产生细胞(pc)。供体反应性 IFN-γ和 GrB pc 的数量明显低于第三方反应性 IFN-γ和 GrB pc 的数量。移植后,供体反应性和第三方反应性与移植前的值相当。在供体和受者之间以及供体反应性 T 细胞应答之间,没有发现 mHAg 错配的关系。
在 HLA 相同的 LR 肾移植前后可以检测到供体反应性,但与 mHAg 错配的数量无关,并且在移植后不会减少。